Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
136
Publications avec texte intégral
Open Access
53 %
Mots clés
Mouse model
Myostatin
Heart
Acetylcholinesterase deficiency
Aging
Myelin
Knockout
Centronuclear myopathy
Diaphragm
Cell culture model
Myotonic Dystrophy
BIOLOGIE MOLECULAIRE
GABA
Muscular dystrophy
KNOCKOUT MICE
RNA splicing
Brain dysfunction
Exercice
Alternative splicing
Hypoxia
CMS
Long read sequencing
Muscle
Antisense oligonucleotide
Antisense oligonucleotides
Intermediate filament
Dynamin 2
Cell penetrating peptide
Exercise
Autophagy
Oligodendrocyte
Acute coronary syndrome
Humans
Maximal force
CTG repeat instability
GSK3
DMSXL mice
Dystrophie Myotonique
Myotonic dystrophy type 1
DM1
Cytoskeleton
Neuron
Therapy
Glucocorticoids
Myotonic Dystrophy type 1
MBNL
Transgenic mouse model
PacBio
Myotonic dystrophy mouse models
Skeletal muscle
Mouse models
Genotype phenotype correlation
Glutamate
Heart failure
CRISPR/Cas9
CTG repeat contractions
Transgenic mouse
Central nervous system
CTG repeats
Gene therapy
ARN
Fibrosis
Glial cells
RNA biology
Animals
Quantitative microdialysis
PCR
Dystrophin
Myotonic dystrophy
Astrocyte
Gene editing
Duchenne muscular dystrophy
DMPK
Thérapie génique
In vivo
Dystrophie myotonique
Male
Astrocytes
Trinucleotide Repeat Expansion
Trinucleotide repeat expansion
Transcriptomics
Cell model
AAV
RNA interference
Dilated cardiomyopathy
Desmin
CRISPRi
Myotonic Dystrophy Type 1
Expression
ACETYLCHOLINESTERASE
Cardiac muscle
Endurance training
Acetylcholinesterase knockout mouse
Mice
CONGENITAL MYATHENIC SYNDROME
Glucocorticoid-receptor
Gene Therapy
Oligodendrocytes
Motoneuron
Brain